Interim report April-June 2018
Vicore Pharma Holding (publ) (ticker: VICO) publish the interim report for the second quarter 2018.Important events during the second quarter · In April, Vicore Pharma received approval to start a Phase IIa study in IPF · In May, Vicore Pharma Holding’s financial asset, I-Tech AB (publ), issued new shares in conjunction with the company’s share listing on Nasdaq First North Important events after the period · In July, Vicore Pharma Holding announced it had entered into an agreement to acquire INIM Pharma AB, a Swedish biopharmaceutical company developing a new local